<h1>Mounjaro Treatment Guide: What Indian Diabetes Patients Should Expect in First Four Weeks</h1> A news article provides guidance for Indian patients beginning Mounjaro (tirzepatide) treatment for type 2 diabetes, outlining expectations for the first four weeks. Week 1 focuses on injection adjustment, with patients experiencing minimal pain but possible tiredness and nausea as the body adapts. By Week 2, blood sugar stabilization becomes noticeable, with reduced post-meal spikes, though mild hypoglycemia risk exists if combined with other diabetes medications. Week 3 typically brings appetite reduction and initial weight loss of 1-3 kg due to slower gastric emptying. Common side effects include digestive discomfort, nausea, and constipation in early weeks, followed by appetite changes and potential mood fluctuations. The article emphasizes when to contact healthcare providers, including persistent side effects lasting over three days, unexplained low blood sugar, injection site reactions, or emotional changes. Patients are advised to maintain realistic expectations, track symptoms, and work closely with doctors for dose adjustments and ongoing care management.